231 related articles for article (PubMed ID: 7545503)
1. The chronic presence of the parasite, and anti-P autoimmunity in Chagas disease: the Trypanosoma cruzi ribosomal P proteins, and their recognition by the host immune system.
Kaplan D; Vazquez M; Lafon S; Schijman AG; Levitus G; Levin MJ
Biol Res; 1993; 26(1-2):273-7. PubMed ID: 7545503
[TBL] [Abstract][Full Text] [Related]
2. Humoral autoimmune response in Chagas' disease: Trypanosoma cruzi ribosomal antigens as immunizing agents.
Levin MJ; Kaplan D; Ferrari I; Arteman P; Vazquez M; Panebra A
FEMS Immunol Med Microbiol; 1993 Oct; 7(3):205-10. PubMed ID: 7506093
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi acidic ribosomal P protein gene family. Novel P proteins encoding unusual cross-reactive epitopes.
Skeiky YA; Benson DR; Guderian JA; Sleath PR; Parsons M; Reed SG
J Immunol; 1993 Nov; 151(10):5504-15. PubMed ID: 7693813
[TBL] [Abstract][Full Text] [Related]
4. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
7. Human humoral immunity to hsp70 during Trypanosoma cruzi infection.
Engman DM; Dragon EA; Donelson JE
J Immunol; 1990 May; 144(10):3987-91. PubMed ID: 2110215
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi: identification and characterization of a novel ribosomal protein L27 (TcrL27) that cross-reacts with an affinity-purified anti-Sm antibody.
Perone D; Santos MA; Peixoto MS; Cicarelli RM
Parasitology; 2003 Jun; 126(Pt 6):577-83. PubMed ID: 12866796
[TBL] [Abstract][Full Text] [Related]
9. Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease.
Levin MJ; Mesri E; Benarous R; Levitus G; Schijman A; Levy-Yeyati P; Chiale PA; Ruiz AM; Kahn A; Rosenbaum MB
Am J Trop Med Hyg; 1989 Nov; 41(5):530-8. PubMed ID: 2479275
[TBL] [Abstract][Full Text] [Related]
10. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
Gironès N; Cuervo H; Fresno M
Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
[TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients.
Skeiky YA; Benson DR; Parsons M; Elkon KB; Reed SG
J Exp Med; 1992 Jul; 176(1):201-11. PubMed ID: 1377223
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a Trypanosoma cruzi antigen with homology to intracellular mammalian lectins.
Macêdo CD; DaRocha WD; Mortara RA; Prado MA; Teixeira SM
Int J Parasitol; 2006 Dec; 36(14):1473-84. PubMed ID: 17027760
[TBL] [Abstract][Full Text] [Related]
14. cDNA cloning and partial characterization of amastigote specific surface protein from Trypanosoma cruzi.
Olivas-Rubio M; Hernández-Martínez S; Talamás-Rohana P; Tsutsumi V; Reyes-López PA; Rosales-Encina JL
Infect Genet Evol; 2009 Dec; 9(6):1083-91. PubMed ID: 19481174
[TBL] [Abstract][Full Text] [Related]
15. Is there a link between the human TRIM21 and Trypanosoma cruzi Clone 36 genes in Chagas' disease?
Winkler MA; Pan AA
Mol Immunol; 2010; 48(1-3):365-7. PubMed ID: 20709399
[TBL] [Abstract][Full Text] [Related]
16. Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein.
Díez H; Guzmán F; Alba MP; Cuéllar A; Thomas MC; López MC; Rosas F; Velasco V; González JM; Patarroyo ME; Puerta CJ
Peptides; 2007 Aug; 28(8):1520-6. PubMed ID: 17683828
[TBL] [Abstract][Full Text] [Related]
17. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients.
Vasconcelos RH; Azevedo EA; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
Hum Immunol; 2011 May; 72(5):402-5. PubMed ID: 21371515
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant antibodies against Trypanosoma cruzi ribosomal P2β protein.
Grippo V; Niborski LL; Gomez KA; Levin MJ
Parasitology; 2011 May; 138(6):736-47. PubMed ID: 21414241
[TBL] [Abstract][Full Text] [Related]
20. The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition.
Lopez Bergami P; Gómez KA; Levy GV; Grippo V; Baldi A; Levin MJ
Clin Exp Immunol; 2005 Oct; 142(1):140-7. PubMed ID: 16178868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]